143 related articles for article (PubMed ID: 31882968)
1. Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients.
Carr MT; Hochheimer CJ; Rock AK; Dincer A; Ravindra L; Zhang FL; Opalak CF; Poulos N; Sima AP; Broaddus WC
Sci Rep; 2019 Dec; 9(1):20018. PubMed ID: 31882968
[TBL] [Abstract][Full Text] [Related]
2. Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
Shieh LT; Guo HR; Ho CH; Lin LC; Chang CH; Ho SY
PLoS One; 2020; 15(5):e0233188. PubMed ID: 32413077
[TBL] [Abstract][Full Text] [Related]
3. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
4. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
Pérez-Beteta J; Martínez-González A; Molina D; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; López C; Claramonte M; Barcia JA; Iglesias L; Avecillas J; Albillo D; Navarro M; Villanueva JM; Paniagua JC; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Delgado MD; Del Valle A; Falkov A; Schucht P; Arana E; Pérez-Romasanta L; Pérez-García VM
Eur Radiol; 2017 Mar; 27(3):1096-1104. PubMed ID: 27329522
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Common Clinical Characteristics and Postoperative Morbidity and Overall Survival in Patients with Glioblastoma.
Liu W; Qdaisat A; Yeung J; Lopez G; Weinberg J; Zhou S; Cohen L; Bruera E; Yeung SJ
Oncologist; 2019 Apr; 24(4):529-536. PubMed ID: 30049883
[TBL] [Abstract][Full Text] [Related]
7. A 4-gene panel predicting the survival of patients with glioblastoma.
Guo XX; Su J; He XF
J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
[TBL] [Abstract][Full Text] [Related]
8. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
9. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
[TBL] [Abstract][Full Text] [Related]
10. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
Haque W; Verma V; Butler EB; Teh BS
Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
[TBL] [Abstract][Full Text] [Related]
12. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
13. Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.
Palmer JD; Bhamidipati D; Shukla G; Sharma D; Glass J; Kim L; Evans JJ; Judy K; Farrell C; Andrews DW; Wang ZW; Peiper SC; Werner-Wasik M; Shi W
Am J Clin Oncol; 2019 May; 42(5):481-486. PubMed ID: 30973372
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
15. Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas.
Gessler F; Bernstock JD; Braczynski A; Lescher S; Baumgarten P; Harter PN; Mittelbronn M; Wu T; Seifert V; Senft C
Neurosurgery; 2019 Jan; 84(1):190-197. PubMed ID: 29617848
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
17. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
Liu B; Liu J; Liao Y; Jin C; Zhang Z; Zhao J; Liu K; Huang H; Cao H; Cheng Q
Med Sci Monit; 2019 May; 25():3624-3635. PubMed ID: 31094363
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance diffusion metrics indexing high focal cellularity and sharp transition at the tumour boundary predict poor outcome in glioblastoma multiforme.
Jamjoom AA; Rodriguez D; Rajeb AT; Manita MA; Shah KA; Auer DP
Clin Radiol; 2015 Dec; 70(12):1400-7. PubMed ID: 26403545
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
